{"id":197,"date":"2023-03-11T17:13:49","date_gmt":"2023-03-11T17:13:49","guid":{"rendered":"https:\/\/arcaid-h2020.eu\/?page_id=197"},"modified":"2023-03-17T14:00:21","modified_gmt":"2023-03-17T14:00:21","slug":"fatemeh_longbio","status":"publish","type":"page","link":"https:\/\/arcaid-h2020.eu\/?page_id=197","title":{"rendered":"Fatemeh_LongBio"},"content":{"rendered":"

\"\"Fatemeh Khodadustvaskasi<\/span><\/strong><\/span><\/p>\n

ESR18- <\/span><\/strong><\/span> Molecular imaging of angiogenesis and therapeutic effects of anti-angiogenetic agents in rheumatoid arthritis<\/strong><\/span><\/p>\n

Studying radiology as my bachelor\u2019s degree along with my master\u2019s degree, radiopharmaceutical sciences, provide me with a comprehensive skills and broad view in wide variety of imaging modalities.<\/span><\/p>\n

I have knowledge and experiences in radiopharmacy, radiolabeling, stability test, affinity assay,cell culture,biodistribution, human xenograft tumor mouse model, the preparation, quality control and supply of radiopharmaceuticals, biomolecules and labeled compounds, ability to work with analytical devices (TLC, HPLC) and also different imaging modalities, such as MRI, CT, X-ray tube, mammography, SPECT.<\/span><\/p>\n

The title of my master\u2019s thesis was \u201cthe influence of HYNIC chelator with Edda\/Tricine as colignds on the specific uptake and the biodistribution of SSSLTVSPWYP peptide for imaging of ovarian cancer with overexpression of HER2\u201d.<\/span><\/p>\n

This developed peptide has been proven to exhibit high contrast tumor uptake both in biodistribution data and SPECT imaging which led to further examination by my knowledgeable research group to test it for clinical application. Simultaneously, I was involved in another project with the same peptide evaluating the influence of a co-ligand for improving the targeting and imaging of HER2 overexpression tumor. I have two publication related to my master thesis:<\/span><\/p>\n